TERN Dividend History & Analysis | N/A Yield
TERN has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| SIGA | 598 M | 7.25% | 12.6% |
| PFE | 140,547 M | 8.68% | 7.89% |
| OGN | 1,648 M | 8.89% | 2.20% |
| BMY | 89,213 M | 5.38% | 5.06% |
| GS71 | 94,733 M | 4.03% | 6.98% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| RPRX | 21,583 M | 29.4% | 100% |
| ZTS | 63,490 M | 21.2% | 100% |
| LLY | 739,980 M | 15.1% | 99.5% |
| SIGA | 598 M | 15.5% | 98.8% |
| RDY | 12,030 M | 28.0% | 87.3% |
Similar Stocks with Attractive Dividends - Compare TERN Dividends with its Peer-Group
7.25% Yield
2.90% Yield
3.77% Yield
3.41% Yield
4.47% Yield
3.38% Yield
TERN Dividend History: as of November 2025
No dividends paid yet.TERN Dividend FAQ
Terns Pharmaceuticals (NASDAQ:TERN) is a clinical-stage biopharma focused on small-molecule therapeutics for oncology and obesity. Its lead oncology asset, TERN-701, is an allosteric BCR-ABL tyrosine-kinase inhibitor currently in a Phase 1 trial for chronic myeloid leukemia. In metabolic disease, TERN-501, a liver-targeted thyroid-hormone-receptor-β agonist, is in Phase IIa for metabolic-dysfunction-associated steatohepatitis (MASH), while TERN-601 (an oral GLP-1 receptor agonist) and the TERN-800 series (GIPR modulators) aim to treat obesity.
What is the Dividend Yield of TERN?
As of November 2025, TERN`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 8.26.Does TERN pay a dividend?
As of November 2025 TERN does not pay a dividend.How often does TERN pay dividends?
Over the last 12 months, TERN has issued dividend payments.Will TERN pay dividends in 2025?
The next Ex-Dividend date for Terns Pharmaceuticals (TERN) is currently unknown.What is the next Ex-Dividend Date for TERN?
The next Ex-Dividend date for Terns Pharmaceuticals (TERN) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of TERN?
TERN's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of TERN?
TERN's 5-Year Yield on Cost is -%. If you bought TERN's shares at 18.39 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of TERN?
TERN Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does TERN have a good Dividend Yield?
TERN`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of TERN?
The Dividend Payout Ratio of TERN is unknown.What is the Dividend Rating of TERN?
TERN`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-10-27 02:02